Preferential resistance of dopaminergic neurons to glutathione depletion in a reconstituted nigrostriatal system

Brain Research

Volumn 873, Issue 2, 2000, Pages 203-211

  Nakamura, Ken ^a   Won, Lisa ^a   Heller, Alfred ^a   Kang, Un Jung ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

DARPP 32; Glial fibrillary acidic protein; L buthionine S,R sulfoximine; Parkinson's disease; Reaggregate culture; Tyrosine hydroxylase

Indexed keywords

CATECHOLAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE PEROXIDASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL AGGREGATION; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IN VIVO STUDY; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

ANIMALS; BUTHIONINE SULFOXIMINE; CATECHOLAMINES; CELL AGGREGATION; CELLS, CULTURED; DOPAMINE; FEMALE; FETUS; GLUTATHIONE; MICE; MICE, INBRED C57BL; NEOSTRIATUM; NERVE DEGENERATION; NEURAL PATHWAYS; NEUROGLIA; NEURONS; PARKINSONIAN DISORDERS; PREGNANCY; SUBSTANTIA NIGRA; TIME FACTORS;

EID: 0034637417     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02425-2     Document Type: Article

References (46)

1. Alam Z.I., Daniel S.E., Lees A.J., Marsden D.C., Jenner P., Halliwell B. A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69:1997;1326-1329.
2. Alam Z.I., Jenner A., Daniel S.E., Lees A.J., Cairns N., Marsden C.D., Jenner P., Halliwell B. Oxidative DNA damage in the Parkinsonian brain: an apparent selective increase in 8-hudroxyguanine levels in substantia nigra. J. Neurochem. 69:1997;1196-1203.
3. Andersen J.K., Mo J.Q., Hom D.G., Lee F.Y., Harnish P., Hamill R.W., NcNeill T.H. Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant gluthathione, on the murine nigrostriatal neurons. J. Neurochem. 67:1996;2164-2171.
4. Bencsics C., Wachtel S.R., Milstien S., Hatakeyama K., Becker J.B., Kang U.J. Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts. J. Neurosci. 16:1996;4449-4456.
5. Castellani R., Smith M.S., Richey P.L., Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 737:1996;195-200.
6. Choi H.K., Won L., Heller A. Dopaminergic neurons grown in three-dimensional reaggregate culture for periods of up to one year. J. Neurosci. Methods. 46:1993;233-244.
7. Conover W.J. Practical Nonparametric Statistics. 1980;Wiley, New York.
8. Dexter D.T., Holley A.E., Flitter W.D., Slater T.F., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9:1994;92-97.
9. Dexter D.T., Sian J., Rose S., Hindmarsh J.G., Mann V.M., Cooper J.M., Wells F.R., Daniel S.E., Lees A.J., Schapira A.H.V., Jenner P., Marsden C.D. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol. 35:1994;38-44.
10. Dexter D.T., Weils F.R., Lees A.J. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52:1989;1830-1836.
11. Drukarch B., Jongenelen C.A.M., Schepens E., Lanageveld C.H., Stoof J.C. Glutathione is involved in the granular storage of dopamine in rat PC12 pheochromocytoma dells: Implications for the pathogenesis of Parkinson's disease. J. Neurosci. 16:1996;6038-6045.
12. Giovanni A., Laing L.P., Hastings T.G., Zigmond M.J. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64:1995;1819-1825.
13. Grasbon-Frodl E.M., Andersson A., Brundin P. Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J. Neurochem. 67:1996;1653-1660.
14. Heller A., Won L., Choi H., Helle B., Hoffman P.C. Reaggregate cultures for neruotoxicological studies. Tyson Ca F.J. In Vitro Biological Systems: Preparation and Maintenance. 1993;3389-3394 Academic Press, New York.
15. Hemmendinger L.M., Garber B.B., Hoffmann P.C., Heller A. Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro. Proc. Natl. Acad. Sci. USA. 78:1981;1264-1268.
16. Hoffmann P.C., Hemmendinger L.M., Kotake C., Heller A. Enhanced dopamine cell survival in reaggregates containing telencephalic target cells. Brain Res. 274:1983;275-281.
17. Jenner P., Olanow W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 47:1996;S161-S170.
18. Kontur P.J., Won L.A., Hoffmann P.C., Heller A. Survival of developing dopaminergic neurons in reaggregate tissue culture following treatment with methamphetamine. Neurosci. Lett. 129:1991;254-258.
19. Kuhn H.G., Dickinson-Anson H., Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci. 16:1996;2027-2033.
20. Langeveld C.H., Schepens E., Stoof J.C., Bast A., Drukarch B. Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices. Free Radic. Biol. Med. 19:1995;209-217.
21. Langston J.W. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann. Neurol. 44:1998;S45-S52.
22. Lavoie M.J., Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19:1999;1484-1491.
23. Marttila R.J., Lorentz H., Rinne U.K. Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J. Neurol. Sci. 86:1988;321-331.
24. Mullen R.J., Buck C.R., Smith A.M. NeuN, a neuronal specific nuclear protein in vertebrates. Development. 116:1992;201-211.
25. Mytilineou C., Kokotos L.E., Kramer B.C., Jamindar T., Olanow C.W. Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures. J. Neurochem. 73:1999;112-119.
26. Nakamura K., Wang W., Kang U.J. The role of glutathione in dopaminergic neuronal survival. J. Neurochem. 69:1997;1850-1858.
27. Nakamura K., Wright D.A., Wiatr T., Kowlessur D., Milstien S., Lei X.G., Kang U.J. Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin. J. Neurochem. 14:2000;2305-2314.
28. Pearce R.K.B., Owen A., Daniel S., Jenner P., Marsden C.D. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural. Transm. 104:1997;661-677.
29. Perry T.L., Godin D.V., Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33:1982;305-310.
30. Perry T.L., Hansen S., Jones K. Brain amino acids and glutathione in progressive supranuclear palsy. Neurology. 38:1988;943-946.
31. Perry T.L., Yong V.W. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67:1986;269-274.
32. Petito C.K., Morgello S., Felix J.C., Lesser M.L. The two patterns of reactive astrocytosis in postischemic rat brain. J. Cereb. Blood Flow Metab. 10:1990;850-859.
33. Philbert M.A., Beiswanger C.M., Waters D.K., Reuhl K.R., Lowndesm H.E. Cellular and regional distribution of reduced glutathione in nervous system of rat: histochemical localization by mercury orange and O=phthaldialdehyde-induced histofluorescence. Toxicol. Appl. Pharmacol. 107:1991;215-227.
34. Pileblad E., Magnusson T., Fornstedt B. Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum. J. Neurochem. 52:1989;978-980.
35. Rice M.E., Russo-Menna I. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience. 82:1998;1213-1223.
36. Riederer P., Sofic E., Rausch W.D. Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains. J. Neurochem. 52:1989;515-520.
37. Saggu H., Cooksey J., Dexter D., Wells F.R., Lees A., Jenner P., Marsden C.D. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J. Neurochem. 53:1989;692-697.
38. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., Marsden C.D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36:1994;348-355.
39. Slivka A., Mytilineou C., Cohen G. Histochemical evaluation of glutathione in brain. Brain Res. 409:1987;275-284.
40. Sofic E., Lange K.W., Jellinger K., Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142:1992;128-130.
41. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
42. Toffa S., Kunikowska G.M., Zeng B.Y., Jenner P., Marsden C.D. Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration. J. Neural. Trans. 104:1997;67-75.
43. Vidal L., Heller B., Won L., Heller A. Quantitation of dopaminergic neurons in 3-dimensional reaggregate tissue culture by computer-assisted image analysis. J. Neurosci. Methods. 56:1995;89-98.
44. + toxicity in nigral dopaminergic neurons. NeuroReport. 7:1996;921-923.
45. Won L., Price S., Wainer B.H., Hoffmann P.C., Bolam J.P., Greengard P., Heller A. Correlated light and electron microscopic study of dopaminergic neurons and their synaptic junctions with DARPP-32-containing cells in three-dimensional reaggregate tissue culture. J. Comp. Neurol. 289:1989;165-177.
46. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA. 93:1996;2696-2701.